ORIGINAL ARTICLE. Five-Year Survival Rates and Time Trends of Laryngeal Cancer in the US Population
|
|
- Barrie Herbert Bennett
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Five-Year Survival Rates and Time Trends of Laryngeal Cancer in the US Population Maura Cosetti, MD; Guo-Pei Yu, MD; Stimson P. Schantz, MD Objectives: To provide comprehensive temporal trend analysis of 5-year relative survival rates of laryngeal cancer using the Surveillance, Epidemiology, and End Results database; and to expand on prior reports by including inclusion of laryngeal tumor location, stage, age at diagnosis, treatment strategy, and histologic grade. Design: Retrospective cohort analysis using the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. The Surveillance, Epidemiology, and End Results data were used to design 5 cohorts of patients with laryngeal cancer: , , , , and Fiveyear survival rates were analyzed according to tumor site, stage, and grade; age at diagnosis; and treatment strategy. The joinpoint regression model was used to assess survival trends and their statistical significance. Results: Among patients with supraglottic cancer, 5-year relative survival rates for distant disease worsened over time while rates for local and regional disease did not change (P =.01 and P.05, respectively). For localized glottic cancer, survival remained stable from to However, patients with regional and distant glottic cancer demonstrated a significant decrease in survival in the past 3 decades (P.001). This trend was independent of treatment strategy. Finally, the proportion of well-differentiated tumors in patients with regional laryngeal cancer decreased over time (P.001 for supraglottic and P=.007 for glottic). Conclusions: A decreasing 5-year survival trend was found among patients with glottic cancer who had regional disease and in all patients with distant disease. Histopathologic trends not previously reported in those with laryngeal cancer seem to parallel those seen in other tobacco-related cancers. These trends may reflect the effect of birth cohorts and implicate the relationship between carcinogenic exposure and host factors, rather than the influence of treatment. Arch Otolaryngol Head Neck Surg. 08;134(4):3-379 Author Affiliations: Departments of Otolaryngology (Drs Cosetti, Yu, and Schantz) and Biostatistics and Epidemiology Service (Dr Yu), The New York Eye and Ear Infirmary and New York Medical College, Valhalla (Drs Yu and Schantz), New York, New York. SEVERAL RECENT STUDIES HAVE suggested that the incidence of laryngeal cancer and other smoking-related cancers is declining in North America 1-3 and Western Europe. 4,5 One factor in this decline may be decreased exposure to carcinogens, specifically tobacco. It has been hypothesized that this declining incidence may reflect achievement in antismoking efforts. Diagnostic technology and treatment for laryngeal cancer have undergone significant changes during the past several decades. 1-6 However, the impact of these changes on survival rates of laryngeal cancer remains unclear. A recent study by Hoffman et al 1 reports declining survival among patients with laryngeal cancer in the past 2 decades. Stratification by tumor location is an important aspect of laryngeal cancer survival data because glottic cancer is known to impart a better prognosis than cancers originating in the supraglottis. 7,8 Notably, prior studies have not included other factors known to influence survival, such as histopathologic tumor grade, in their analyses. In this study, we analyzed changes in 5-year survival rate according to laryngeal subsites and tumor stage. We further considered the relationship between these survival trends and age at diagnosis, treatment strategy, and histologic tumor grade. METHODS We obtained data from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute 9 and applied information on cancer diagnosis only to the residents of 9 population-based registries (ie, 5 states [Connecticut, Hawaii, Iowa, New Mexico, and Utah] and 4 standard metropolitan areas [Atlanta, Georgia; Detroit, Michigan; San Francisco Oakland, California; and Seattle Puget Sound, Washington]). We used SEER computer software (Stat 5.2.2) to conduct survival rate analysis. We selected cases of laryngeal cancer that contained follow-up information. The Interna- (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR 08 3 Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
2 tional Classification of Diseases for Oncology site codes used for laryngeal cancer are C3 (glottic), C321 (supraglottic), and C322 to C329 (all other laryngeal cancers). To better estimate the survival of primary laryngeal cancer, we excluded patients whose laryngeal cancer represented a second primary malignant neoplasm. To compare changes in survival rates, we designed 5 patient cohort periods: , , , , and Each of these 5 patient cohorts consists of data from a 2-year registry and contains data for an observation period of 5 years. The design of the cohorts ensured that the individual 5-year observation period for each cohort did not overlap. We assumed that the variation of survival rates of the 5 patient cohorts represented the trend of laryngeal cancer survival from 1977 to 03. Five-year survival data from these patient cohorts were further analyzed according to 2 subsites of the larynx (glottic and supraglottic) and tumor stage at diagnosis (localized, regional, distant, and unknown). In the SEER database, localized disease is defined as a malignancy limited to the organ of origin. 9(p6) Regional disease is defined as 1) extension beyond the limits of the organ of origin directly into surrounding organs or tissues; 2) into regional lymph nodes by way of the lymphatic system; or 3) by a combination of extension and regional lymph nodes. 9(pp5-7) Finally, the SEER program characterizes distant disease as tumor that spread to parts of the body remote from the primary site, either by direct extension or by discontinuous metastasis. 9(p8) Cause of death, as indicated on the death certificate, was grouped into 3 broad categories: laryngeal cancer, all other cancer, and noncancer. Three categories were used to calculate causespecific survival rates for laryngeal cancer (ie, death due to primary laryngeal cancer, death due to metastatic disease or second primary cancer, and non cancer-related death). In addition, treatment modality, including surgery or radiation therapy, was assessed. Within the SEER database, treatment with radiation encompasses all forms of therapy, including external beam, radioactive implants, radioisotopes, or a combination. 9 Information on chemotherapeutic agents is not included in the database. Further analysis was done using patient age at diagnosis. Within each cohort, patients were grouped into 3 broad age categories: to 49 years, to 64 years, and 65 years and older. The Mantel-Haenszel method was used to calculate overall rate ratios (RRs) for 5-year survival rates, period-specific RRs, and 95% confidence intervals (CIs). The survival rates of the period were defined as a reference category and those of subsequent periods were used in comparison. In the analysis, we described age-adjusted incidence rates for glottic and supraglottic cancers to explain the variation of survival over time. To test statistical significance of incidence trends and obtain estimated annual percentage change, we used joinpoint regression to analyze the age-adjusted rates based on 2-year combination. The joinpoint regression model is a statistical method that describes changing trends over successive segments of time and the amount of increase or decrease within each segment. 11,12 The statistics derived from these models are the estimated annual percentage change and 95% CIs of the estimated annual percentage changes. RESULTS INCIDENCE Age-adjusted incidence rates for glottic and supraglottic cancer are shown in Figure 1. Overall, incidence trends at both sites varied with age and stage. A significant decrease in the incidence of local supraglottic cancer over time was found among all age groups (Figure 1D-F). In the oldest age group (those 65 years), the incidence of regional supraglottic disease increased (Figure 1F). For glottic cancer, the incidence of local and regional disease decreased significantly in the youngest age group (those aged -49 years) (Figure 1A). In the - to 64- year-old subjects and in those 65 years and older, this decreased incidence was seen only in localized glottic disease (Figure 1B and C). Overall, incidence trends for regional glottic cancer were nonsignificant in both older age groups (Figure 1B and C). SURVIVAL Figure 2 depicts 5-year relative survival rates for supraglottic cancer. In , the 5-year survival was 63.0% for localized disease, 46.1% for regional disease, and 6.4% for distant disease. While survival rates for local and regional stage supraglottic cancer have not significantly changed over time, a significant decrease was found in 5-year survival of distant stage supraglottic cancer (Figure 2C). Survival trends of glottic cancer also differ by stage (Figure 3). The most current 5-year survival statistics by stage are as follows: from , 5-year survival was.6% for localized disease,.6% for regional disease, and 27.4% for distant disease. For localized disease (Figure 3A), 5-year relative survival rates were nearly identical for and (89.6% and.6%, respectively). Thus, no significant survival trend was found. On the other hand, a nearly % decrease in survival over time was observed for regional and distant glottic disease (RRs, 0. and 0.74, respectively; P.001 for both). Specifically, the 5-year relative survival rate of regional glottic cancer decreased from 78.6% in to.6% in (Figure 3B); and for distant stage disease, it decreased from 52.7% to 27.4% (Figure 3C). There was no significant change in survival for unstaged disease (Figure 3D). Additional analysis of the decreased survival trend of regional glottic cancer is demonstrated in Table 1. Patients with regional glottic cancer are grouped by age at diagnosis, and survival rates are categorized by cause, thereby distinguishing cancer- and non cancer-related deaths in each age group. In the - to 64-year-old subjects, the 5-year glottic cancer and all cancer specific survival rates significantly decreased between and While not significant, the exact opposite trend was seen in the other 2 age groups: glottic and all cancer related survival rates increased over time in the - to 49-year-old and the 65 years and older age groups. In non cancer-specific survival rates, all groups showed a slight, but insignificant, decrease over time. The RRs (95% CIs) by age are as follows (ratios were calculated by dividing the survival rate of by the survival rate of ). For laryngeal cancer, in the - to 49-year-old group, the RR was 1.1 (95% CI, ); in the - to 64-year-old group, the RR was 0.8 (95% CI, ) (P=.002); and in the 65 years and older group, the RR was 1.1 (95% CI, ). For all cancer, in the - to 49-year-old group, the RR was 1.1 (95% CI, ); in the - to 64-year-old group, the RR was 0.8 (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
3 A 0.8 D 0.5 Localized disease Regional disease 0.7 Age-Adjusted Rate (1/0 000) B 9 E Age-Adjusted Rate (1/0 000) C 9 F Age-Adjusted Rate (1/0 000) Year of Diagnosis Year of Diagnosis Figure 1. Age-adjusted incidence rates for glottic and supraglottic cancers from 1973 to 03 by age and tumor stage. A, Glottic cancer in patients aged to 49 years; B, glottic cancer in patients aged to 64 years; C, glottic cancer in patients 65 years and older; D, supraglottic cancer in patients aged to 49 years; E, supraglottic cancer in patients aged to 64 years; and F, supraglottic cancer in patients 65 years and older. In A, the estimated biannual percentage change (EBAPC) (95% confidence interval [CI]) was 7.3 ( 8.7 to 5.8) for localized disease and 3.7 ( 5.5 to 1.9) for regional disease (P.001 for both). In B, the EBAPC (95% CI) was 2.4 ( 0.1 to 5.0) (P=.06) for localized disease from 1973 to 1985, 9.2 (.6 to 7.7) (P.001) for localized disease from 1985 to 03, and 1.5 ( 3.0 to 0) (P=.05) for regional disease. In C, the EBAPC (95% CI) was 2.1 ( ) (P=.004) for localized disease from 1973 to 1995, 12.2 ( 17.8 to 6.3) (P=.001) for localized disease from 1995 to 03, and 0.7 ( 1.0 to 2.3) (P=.) for regional disease. In D, the EBAPC (95% CI) was 8.6 ( 12.0 to 5.2) (P.001) for localized disease and 1.6 ( 0.3 to 3.7) (P=.) for regional disease. In E, the EBAPC (95% CI) was 4.0 (1.1 to 9.3) (P=.11) for localized disease from 1973 to 1987, 11.1 ( 15.0 to 6.9) (P.001) for localized disease from 1987 to 03, 9.6 (0.1-.1) (P=.05) for regional disease from 1973 to 1983, and 1.6 ( 4.2 to 1.0) (P=.) for regional disease from 1983 to 03. In F, the EBAPC (95% CI) was 7.8 ( ) (P=.04) for localized disease from 1973 to 1983, 4.1 ( 6.3 to 1.8) (P=.002) for localized disease from 1983 to 03, 7.9 ( ) (P.001) for regional disease from 1973 to 1987, and 1.0 ( 3.3 to 1.4) (P=.39) for regional disease from 1987 to 03. (95% CI, ) (P.001); and in the 65 years and older group, the RR was 0.9 (95% CI, ). For non cancerspecific data, in the - to 49-year-old group, the RR was 0.9 (95% CI, ); in the - to 64-year-old group, the RR was 0.9 (95% CI, ); and in the 65 years and older group, the RR was 1.0 ( ). Examining trends in survival of regional stage glottic cancer by age and birth cohort revealed an overall de- (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
4 A 0 C (n = 59) [.5%] (n = 37) [19.1%] (n = 37) [21.9%] (n = 35) [6.4%] (n = 87) Relative (n = 198) [68.2%] (n = 225) [67.1%] (n = 2) [63.7%] (n = 211) [63.0%] (n = 363) B 0 D 0 Relative (n = 264) [46.5%] (n = 332) [41.0%] (n = 366) [46.3%] (n = 424) [46.1%] (n = 43) (n = 13) [41.2%] (n = 28) [46.9%] (n = 25) [44.2%] (n = 19) [46.9%] (n = 31) Figure 2. Time trends of 5-year relative survival rates by tumor stage for supraglottic cancer. A, Local stage; B, regional stage; C, distant stage; and D, unstaged. The overall Mantel-Haenszel method-calculated relative ratio of 5-year survival (other cohorts vs the cohort) was 0.95 in A, 0.96 in B, 0.52 inc,and 1.06 in D. The numbers in parentheses after each period indicate the number of patients at the start of the study, and the percentages in brackets indicate the 5-year relative survival rates. In C, for , the rate ratio (RR) was 0.63 (95% confidence interval [CI], ) (P.05); for , the RR was 0.72 (95% CI, ) (P.05); and for , the RR was 0.21 (95% CI, ) (P=.01). crease in survival in patients of late cohorts (Figure 4). The effect of birth cohort was particularly evident in the survival curve of the group aged to 59 years, with a significant decrease beginning in the 1924 to 1929 cohort (Figure 4B). Restated, patients with regional glottic cancer in this age group had a lower 5-year survival if they were born after Analysis according to treatment strategy is shown in Figure 5. In the - to 64-year-old age group, a decreasing survival trend was observed across all treatments, including surgery only, radiation only, and combined surgery and radiation. Cancer-specific 5-year survival of those with regional glottic cancer did not vary with treatment modality. A significant trend in survival was found in non cancer-specific mortality in patients treated with surgery only (Figure 5D). Further analysis on the proportion of patients treated with each modality is depicted in Table 2. Over time, there is a significant trend toward increased use of radiation therapy and decreased treatment with surgery alone. Last, regional stage tumors in this age group were classified according to histologic tumor grade (Table 3 and Table 4). The proportion of well-differentiated tumors in patients with regional glottic disease decreased significantly over time. In , 28.2% of regional disease was histologically well differentiated, significantly higher than the 15.8% of well-differentiated disease seen in No significant time-dependent changes in tumor grade were found in localized disease. A similar trend was found in regional supraglottic disease. COMMENT Release of newly expanded data from the SEER database program has prompted a reexamination of survival rates for a multitude of cancer types. Laryngeal cancer was unique among this group of 24 cancers as the only type to experience a decrease in 5-year survival rates. 1 In a recent analysis of the SEER database, Carvalho et al 13 report survival trends for various sites of head and neck cancer. In their analysis of laryngeal cancer, they report a decrease in 5-year survival for local disease, no change for patients with regional disease, and an improvement in 5-year survival in distant or late-stage laryngeal cancer. These results seem to conflict with the findings of (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
5 A C Relative (n = 634) [89.6%] (n = 0) [.3%] (n = 676) [86.7%] (n = 916) [.6%] (n = 378) (n = 21) [52.7%] (n = 23) [48.2%] (n = 11) [39.5%] (n = 16) [27.4%] (n = 22) B 0 D 0 Relative (n = 244) [78.6%] (n = 291) [63.9%] (n = 252) [64.7%] (n = 334) [.6%] (n = 834) (n = ) [69.2%] (n = 39) [76.5%] (n = 87) [61.6%] (n = 38) [73.2%] (n = 53) Figure 3. Time trends of 5-year relative survival rates by tumor stage for glottic cancer. A, Local stage; B, regional stage; C, distant stage; and D, unstaged. The Mantel-Haenszel method-calculated relative ratio of 5-year survival (other cohorts vs the cohort) was 1.00 in A, 0. in B, 0.74 in C, and 1.02 in D. The numbers in parentheses after each year indicate the number of patients at the start of the study, and the percentages in brackets indicate the 5-year relative survival rates. In B, for , the rate ratio (RR) was 0.81 (95% confidence interval [CI], ); for , the RR was 0.82 (95% CI, ); and in , the RR was 0.77 (95% CI, ) (P.001 for all periods). this study. One explanation for this discrepancy lies in the years of data included in each analysis. Carvalho et al use the SEER data from 1974 to 1997 in their calculation of overall survival trends; however, in their analysis of stage-specific survival, they include only the data from 1983 to In doing so, they exclude a period of relatively improved survival for regional and distant disease reported from 1974 to Exclusion of these data would contribute to the variance in results between studies. In addition, Carvalho et al grouped all subsites of laryngeal cancer, rather than a separate analysis of glottic vs supraglottic cancer, thus adding to the differences between studies. A recent report by Hoffman et al 1 also examined trends in laryngeal cancer survival in the past 2 decades. Using the National Cancer Data Base and SEER data, their study reports a decrease in survival of patients with glottic and supraglottic laryngeal cancer that varied by TNM stage. 1 In general, the results of the present study support those of Hoffman et al and report a more pronounced decline in survival in patients with advanced stage disease. The present report uses the SEER database program to analyze 5-year survival in patients with laryngeal cancer by age, laryngeal subsite, tumor stage, histologic grade, and treatment strategy. Overall, the data depict a significant decline in survival in patients with regional stage glottic cancer; from 1977 through 03, a nearly % decrease in 5-year survival rates of advanced glottic cancer was observed. In addition, a significant decrease was found in survival rates of distant disease of glottic and supraglottic cancer during these 2 decades. There are multiple factors that may explain these results, including (1) the phenomenon of stage drift; (2) changing trends in treatment; (3) spurious data from the early cohorts; (4) the nature of relative survival rates and the impact of comorbidities; (5) a change in causative factors or carcinogenic exposure, such as tobacco; and (6) a change in the disease itself. To begin, the confounding influence of stage drift can be created by advances in diagnostic technology. Specifically, a lesion classified as early-stage disease in the pre computed tomographic scan era would be diagnosed as advanced when more sophisticated imaging is used. Therefore, a trend toward increased incidence of advanced disease may reflect the introduction and application of improved diagnostic technology and not a change in the (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
6 Table 1. Time Trend of Cause-Specific 5-Year Observed Survival Rates by Age for Patients With Regional Stage Glottic Cancer a Cause-Specific 5-y Observed Survival Age Group, y No. of Patients Alive at Start Laryngeal Cancer Specific All Cancer Specific Noncancer Specific (7.7) 71.3 (8.6) 95.1 (4.8) (8.0) 78.7 (8.5).0 (6.7) (6.1) 78.6 (7.8) 95.5 (4.4) (7.8) 81.1 (8.5) 85.8 (7.7) (2.9) 83.2 (3.6).4 (2.9) (3.7).4 (4.2) 81.5 (3.6) (4.0) 69.5 (4.8) 84.7 (3.9) (3.9) 63.3 (4.2) 81.9 (3.8) (4.9) 68.3 (5.0) 77.7 (4.7) (4.5) 61.4 (4.7) 78.0 (4.5) (4.6) 63.4 (4.9) 74.9 (4.5) (3.7) 62.1 (4.1) 75.1 (3.9) a Data are given as rate (SE), measured in percentages, for each age group at each year. aggressiveness or behavior of the disease itself. The overall trends in our data support a decreasing incidence in local disease and an increase in regional disease over the period studied. On the other hand, stage drift would likely lead to a positive survival trend in categorical groupings. For example, as radiologic sophistication restaged early disease as more advanced, the advanced cancer group would be diluted with patients who demonstrate an earlier form of the disease. Thus, stage drift would likely manifest in an overall increase in survival of advanced stage cancer. However, this was not demonstrated in our results. In fact, our data support the opposite (ie, a decrease in survival of regional stage glottic cancer). Thus, the complex phenomenon of stage drift cannot solely account for the results of this study. Not only the diagnostic modalities but also the treatment of laryngeal cancer has changed in the past years. More important, nonsurgical treatment, specifically radiation and chemotherapy, was introduced and widely applied to laryngeal carcinoma. 1 As depicted in Figure 5, however, the decrease in survival of regional glottic cancer is likely not entirely attributable to a change in treatment strategy. The magnitude of decrease in cancerspecific survival rates was approximately % for all treatment modalities, including surgery, radiation, and combined therapy, from 1977 to Throughout the period examined, there was a significant trend toward more frequent use of radiation therapy alone and decreased use of surgery alone. While reflecting an evolving treatment paradigm in laryngeal cancer, patients in each treatment modality demonstrated decreased survival over time. Evidence of the insignificance of treatment modality is also found in the stable survival trends among patients with regional glottic cancer of the age groups to 49 years and 65 years and older. If treatment plays a role in promoting survival, it should impact all ages rather than only patients aged to 64 years, unless different treatments are used at different ages. These data are not an appropriate evaluation of therapeutic effectiveness of a given treatment modality. However, they do demonstrate a consistent decrease in relative survival independent of changes or trends in treatment strategy. Analysis of the data must mention the possibility of spurious results. In Figure 4, patients in the earliest cohorts demonstrate strikingly good survival. It is possible that these data are spurious and inappropriately influence the analysis toward significance. Another potentially confounding factor is the influence of comorbid disease. Survival rates in this study refer to relative survival rates. As the treatment of comorbidities improves with time, patients in later cohorts may survive their comorbid disease and succumb to laryngeal carcinoma. This is somewhat unlikely, however, because this confounding variable should influence all patients within a given cohort equally. Finally, the decrease in survival of patients with regional glottic carcinoma may be explained by a change in causative factors, including carcinogenic exposure. The relationship between carcinogens, specifically tobacco and alcohol, and laryngeal cancer has long been recognized Shifting trends in tobacco use may be implicated in observed changes in survival statistics and disease characteristics. Although the absolute number of tobacco users has decreased dramatically since 1965, recent reports 17,18 suggest that this may disproportionately represent the occasional or limited tobacco user. From 1993 to 00, the percentage of smokers who report everyday tobacco use has increased. 17,18 Thus, while overall tobacco use has clearly decreased, there seems to be a trend toward increased intensity among remaining smokers. Prior research 19 examining carcinogenic exposure on a cellular level has linked intensity of carcinogenic exposure, amount of genetic damage, and carcinogenesis. This positive relationship supports the idea that increasing intensity of tobacco exposure may be related to the increased incidence and decrease survival of late-stage disease. (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
7 A D (n = 25) [92.0%] (n = 26) [79.7%] (n = 19) [72.3%] (n = 34) [63.7%] (n = 94) (n = 44) [83.0%] (n = 46) [68.5%] (n = 49) [.3%] (n = 56) [63.9%] (n = 23) B 0 E (n = 44) [82.7%] (n = 48) [55.0%] (n = 34) [62.4%] (n = 57) [62.9%] (n = 3) (n = ) [.7%] (n = 36) [63.5%] (n = 33) [73.0%] (n = 46) [69.4%] (n = 99) C (n = 44) [78.8%] (n = 62) [77.1%] (n = ) [73.4%] (n = 51) [63.5%] (n = 134) Figure 4. Cancer-specific survival rates by age and birth cohort for patients with regional stage glottic cancer. A, Patients aged to 54 years; B, patients aged 55 to 59 years; C, patients aged to 64 years; D, patients aged 65 to 69 years; and E, patients aged to 74 years. The overall Mantel-Haenszel method-calculated rate ratio (RR) of cancer-specific survival was 0.78 (95% confidence interval [CI], ) (P=.003) in A, 0.73 (95% CI, ) (P.001) in B, 1.66 (95% CI, ) (P=.) in C, 0.81 (95% CI, ) (P=.005) in D, and 1.35 (95% CI, ) (P=.03) in E. The numbers in parentheses after each year indicate the number of patients at the start of the study, and the percentages in brackets indicate the 5-year relative survival rates. In A, for 1929 to 1934, the RR was 0.87 (95% CI, ) (P=.39); for 1935 to 19, the RR was 0.79 (95% CI, ) (P=.18); and for 1941 to 1946, the RR was 0.69 (95% CI, ) (P=.03). In B, for 1924 to 1929, the RR was 0.67 (95% CI, ) (P=.009); for 19 to 1935, the RR was 0.76 (95% CI, ) (P=.08); and for 1936 to 1941, the RR was 0.75 (95% CI, ) (P=.04). In D, for 1914 to 1919, the RR was 0.83 (95% CI, ) (P=.18); for 19 to 1925, the RR was 0.85 (95% CI, ) (P=.24); and for 1926 to 1931, the RR was 0.77 (95% CI, ) (P=.04). In addition, histologic changes in disease characteristics seem to parallel trends in tobacco use and disease survival. To our knowledge, trends in histopathologic differentiation among laryngeal cancer tumors have not been previously reported. However, this phenomenon has been examined in other tobacco-related cancers, specifically lung cancer. The leading histologic type of lung cancer has undergone a well-documented shift from a squa- (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
8 A 0 D (n = 41) [84.8%] (n = 38) [66.8%] (n = 19) [.3%] (n = 26) [57.8%] (n = 64) (n = 41) [95.0%] (n = 38) [73.2%] (n = 19) [67.5%] (n = 26) [73.4%] (n = 64) B 0 E (n = 37) [82.1%] (n = 45) [73.3%] (n = ) [69.5%] (n = 51) [66.6%] (n = 145) (n = 37) [85.6%] (n = 45) [87.9%] (n = ) [89.5%] (n = 51) [85.4%] (n = 145) C 0 F (n = ) [82.8%] (n = 47) [68.7%] (n = ) [71.0%] (n = 54) [67.9%] (n = 96) (n = ) [88.6%] (n = 47) [86.7%] (n = ) [87.4%] (n = 54) [87.3%] (n = 96) Figure 5. Survival rates for patients with regional stage glottic cancer aged to 64 years. A, Cancer-specific rates for those who underwent surgery only; B, cancer-specific rates for those who underwent radiation only; C, cancer-specific rates for those who underwent surgery and radiation; D, non cancer-specific rates for those who underwent surgery only; E, non cancer-specific rates for those who underwent radiation only; and F, non cancer-specific rates for those who underwent surgery and radiation. The overall Mantel-Haenszel method-calculated rate ratio of survival was 0.76 (P.001) in A, 0.85 (P=.04) in B, 0.84 (P=.03) in C, 0.76 (P.001) in D, 1.02 (P=.83) in E, and 0.98 (P=.) in F. In A, for , the rate ratio (RR) was 0.79 (95% confidence interval [CI], ) (P=.11); for 1989 to 19, the RR was 0.83 (95% CI, ) (P=.34); for 1995 to 1996, the RR was 0.68 (95% CI, ) (P=.03). In B, for , the RR was 0.89 (95% CI, ) (P=.); for , the RR was 0.85 (95% CI, ) (P=.36); and for , the RR was 0.81 (95% CI, ) (P=.17). In C, for , the RR was 0.83 (95% CI, ) (P=.27); for , the RR was 0.86 (95% CI, ) (P=.36); and for , the RR was 0.82 (95% CI, ) (P=.22). In D, for , the RR was 0.77 (95% CI, ) (P=.02); for , the RR was 0.71 (95% CI, ) (P=.01); and for , the RR was 0.77 (95% CI, ) (P=.03). mous cell carcinoma to adenocarcinoma, and this evolution has paralleled the change in cigarette composition and tobacco use. 3, The introduction and widespread use of filtered cigarettes in the 19s is believed to have changed smoking behaviors and may account for the histologic trends observed in lung cancer. 3,,21 Thun et al (p15) suggest that the increase in lung adenocarcinoma since the 19s is more consistent with changes in smoking behavior and cigarette design than with diagnostic advances. Our histologic analysis of regional (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
9 Table 2. Treatment of Patients With Regional Stage Glottic Cancer, Aged to 64 Years, Over Time a Type of Treatment (n = 113) (n = 136) (n = 3) (n = 142) (n = 331) b Surgery alone 41 (36.3) 38 (27.9) 19 (18.4) 26 (18.3) 64 (19.3) Radiation alone 37 (32.7) 45 (33.1) (29.1) 51 (35.9) 145 (43.8) Surgery plus radiation (26.5) 47 (34.6) (48.5) 54 (38.0) 96 (29.0) No surgery or no radiation 3 (2.7) 0 2 (1.9) 6 (4.2) 3 (0.9) Surgery or radiation refused 2 (1.8) 0 1 (1.0) 2 (1.4) 1 (0.3) Unknown surgery or radiation 0 6 (4.4) 1 (1.0) 3 (2.1) 22 (6.6) a Data are given as number (percentage) of patients. Column percentages may not total 0 because of rounding = (P.001) for testing the trend of treatment modality. b The increase in number of patients with glottic cancer is because of an increase in the population included in the Surveillance, Epidemiology, and End Results (SEER) database. The SEER regional catchment areas increased from 9 in 1973 to 1991 to 13 in 1992 to 1999 and to 17 in 00 to 03. Table 3. Histologic Grade of Glottic Cancer by Year of Diagnosis for Patients Aged to 64 Years a Year of Diagnosis Stage of Cancer Regional Well differentiated 33 (28.2) 29 (.6) 18 (17.3) 27 (18.6) 53 (15.8) Moderately differentiated 46 (39.3) 55 (39.0) 51 (49.0) 76 (52.4) 192 (57.3) Poorly differentiated 15 (12.8) 21 (14.9) 18 (17.3) 22 (15.2) 57 (17.0) Undifferentiated 0 3 (2.1) 1 (1.0) 2 (1.4) 1 (0.3) Unknown 23 (19.7) 33 (23.4) 16 (15.4) 18 (12.4) 32 (9.6) Total b 117 (0.0) 141 (0.0) 4 (0.0) 145 (0.0) 335 (0.0) Localized Well differentiated 81 (27.6) 94 (29.8) (26.7) 78 (25.9) 125 (26.2) Moderately differentiated 91 (31.0) 9 (34.6) 93 (35.5) 135 (44.9) 213 (44.6) Poorly differentiated 19 (6.5) (6.3) 25 (9.5) 27 (9.0) 29 (6.1) Undifferentiated (0.7) 2 (0.4) Unknown 3 (35.0) 92 (29.2) 74 (28.2) 59 (19.6) 9 (22.8) Total b 294 (0.0) 315 (0.0) 262 (0.0) 1 (0.0) 478 (0.0) a Data are given as number (percentage) of patients in each period for each stage of cancer. For regional data: 2 1 = 7.25 (P =.007) for testing the trend of proportion of well-differentiated tumor. For localized data: 2 1 = 0.81 (P =.37) for testing the trend of proportion of well-differentiated tumor. b The sum of column percentages may not total 0 because of rounding. Table 4. Histologic Grade of Supraglottic Cancer by Year of Diagnosis for Patients Aged to 64 Years a Year of Diagnosis Stage of Cancer Localized Well differentiated 22 (18.3) (16.9) 15 (15.0) (11.1) (12.5) Moderately differentiated 43 (35.8) 54 (45.8) (.0) 49 (54.4) 83 (51.9) Poorly differentiated 22 (18.3) (16.9) 26 (26.0) 17 (18.9) 25 (15.6) Undifferentiated 2 (1.7) 2 (1.7) 4 (4.0) 2 (2.2) 1 (0.6) Unknown 31 (25.8) 22 (18.6) 15 (15.0) 12 (13.3) 31 (19.4) Total b 1 (0.0) 118 (0.0) 0 (0.0) (0.0) 1 (0.0) Regional Well differentiated 16 (11.3) 23 (13.6) (5.6) 15 (8.6) 28 (5.6) Moderately differentiated 65 (45.8) 58 (34.3) 89 (.3) 81 (46.3) 263 (52.6) Poorly differentiated 26 (18.3) 43 (25.4) 59 (33.3) 62 (35.4) 137 (27.4) Undifferentiated 4 (2.8) 6 (3.6) 1 (0.6) 4 (2.3) 9 (1.8) Unknown 31 (21.8) 39 (23.1) 18 (.2) 13 (7.4) 63 (12.6) Total b 142 (0.0) 169 (0.0) 177 (0.0) 175 (0.0) 0 (0.0) a Data are given as number (percentage) of patients. For localized stage: 2 1 = 2.82 (P =.09) for testing the trend of proportion of well-differentiated tumor. For regional stage, 2 1 = 9.42 (P.001) for testing the trend of proportion of well-differentiated tumor. b The sum of column percentages may not total 0 because of rounding. (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
10 laryngeal cancer also documents a shift toward less differentiation, which seems to parallel decreasing survival trends and changing patterns in tobacco use. These data address the complex interaction between causative agents, including known carcinogens, such as tobacco and alcohol, and host factors that affect disease manifestation and patient survival. The present study used fixed patient cohorts to describe temporal trends of survival in laryngeal cancer. Each of these cohorts had at least a 5-year observation period for survival, and these windows did not overlap each other in time. These methodological considerations are important in the use of cancer registry patients for whom follow-up periods are varied. In general, cancer survival is relatively high during the first several years. Because the last patient cohorts had observation periods of less than 5 years, their survival rate may be higher than those of earlier cohorts, with a greater window of observation. Our analysis excluded patients with second or later cancer primary tumors. Such exclusion is necessary for analysis of cause-specific survival. Inherent in any database analysis, however, is the possibility of incorrect diagnosis or inappropriate attribution of mortality to non cancer-related death when, in fact, a second primary or metastatic disease may be culpable. In conclusion, decreasing 5-year relative survival trends were demonstrated among patients with glottic cancer and regional disease and in patients with both glottic and supraglottic cancer as well as distant disease. Histopathologic trends not previously reported in laryngeal cancer seem to parallel those seen in other tobacco-related cancers. These trends may reflect the effect of birth cohorts with a unique exposure to carcinogens and changing trends in tobacco use over time, rather than an influence of treatment modality. Further research into the biological, genetic, and environmental interactions between carcinogenic exposure, specifically tobacco, and laryngeal cancer is warranted. Submitted for Publication: January 26, 07; final revision received August 21, 07; accepted September 4, 07. Correspondence: Stimson P. Schantz, MD, Department of Otolaryngology, The New York Eye and Ear Infirmary, 3 E 14th St, New York, NY 003 Author Contributions: Drs Cosetti, Yu, and Schantz had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Cosetti, Yu, and Schantz. Acquisition of data: Yu. Analysis and interpretation of data: Cosetti, Yu, and Schantz. Drafting of the manuscript: Cosetti and Schantz. Critical revision of the manuscript for important intellectual content: Cosetti, Yu, and Schantz. Statistical analysis: Yu. Administrative, technical, and material support: Schantz. Study supervision: Schantz. Financial Disclosure: None reported. Previous Presentation: This study was presented as a poster at the Annual Meeting of The Triologic Society; May -22, 06; Chicago, Illinois. REFERENCES 1. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care and survival. Laryngoscope. 06; 116(9, pt 2)(suppl 111): McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 19s. J Clin Oncol. 00;18(11): Wingo PA, Ries LA, Giovino GA, et al. Annual report to the nation on the status of cancer, , with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91(8): Capocaccia R, Micheli A, Berrino F, et al. Time trends of lung and larynx cancers in Italy. Int J Cancer. 1994;57(2): Raitiola HS, Pukander JS. Changing trends in the incidence of laryngeal cancer. Acta Oncol. 1997;36(1): Shah JP, Karnell LH, Hoffman HT, et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg. 1997;123(5): Silvestri F, Bussani R, Stanta G, Cosatti C, Ferlito A. Supraglottic versus glottic laryngeal cancer: epidemiological and pathological aspects. ORL J Otorhinolaryngol Relat Spec. 1992;54(1): Stell PM. Prognosis in laryngeal carcinoma: tumour factors. Clin Otolaryngol Allied Sci. 19;15(1): National Cancer Institute, US National Institutes of Health, Surveillance Research Program, Cancer Statistics Branch, Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence SEER 17 Regions Limited-Use, Nov 05 Submission ( varying): Linked to County Attributes: Total U.S., Accessed April 06.. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8(12): Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 00;19(3): Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999; 91(12): Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 05;114(5): Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking: global estimates for Int J Cancer. 1994;59(4): Cattaruzza MS, Maisonneuve P, Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol. 1996;32B(5): IARC Monographs on the Evaluation of Carcinogenic Risk to Humans: Tobacco Smoking. Vol 38. Lyon, France: International Agency for Research on Cancer, World Health Organization; Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults: United States, MMWR Morb Mortal Wkly Rep. 1994;43(): Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults: United States, 00. MMWR Morb Mortal Wkly Rep. 02;51(29): Schantz SP, Yu GP. The epidemiology of head and neck cancer. In: Fu YS, Wenig B, Abemayor E, Wenig BS, eds. Head and Neck Pathology: With Clinical Correlations. New York, NY: Churchill Livingstone Inc; 01: Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and change in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89(21): Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 03;123(1)(suppl):21S- 49S. (REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/ VOL 134 (NO. 4), APR Downloaded From: on /05/18 08 American Medical Association. All rights reserved.
The projection of short- and long-term survival for. Conditional Survival Among Patients With Carcinoma of the Lung*
Conditional Survival Among Patients With Carcinoma of the Lung* Ray M. Merrill, PhD, MPH; Donald Earl Henson, MD; and Michael Barnes, PhD Objective: One- and 5-year probabilities of survival or death change
More informationChapter 13 Cancer of the Female Breast
Lynn A. Gloeckler Ries and Milton P. Eisner INTRODUCTION This study presents survival analyses for female breast cancer based on 302,763 adult cases from the Surveillance, Epidemiology, and End Results
More informationTrends in Lung Cancer Incidence by Histological Type in Osaka, Japan
Original Article Japanese Journal of Clinical Oncology Advance Access published August 9, 2008 Jpn J Clin Oncol 2008 doi:10.1093/jjco/hyn072 Trends in Lung Cancer Incidence by Histological Type in Osaka,
More informationTrends in Lung Cancer Morbidity and Mortality
Trends in Lung Cancer Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Program Services Division November 2014 Table of Contents Trends in Lung Cancer Morbidity
More informationHypopharyngeal Cancer Incidence, Treatment, and Survival: Temporal Trends in the United States
The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Hypopharyngeal Cancer Incidence, Treatment, and Survival: Temporal Trends in the United States Phoebe Kuo,
More informationOncologist. The. Outcomes Research. Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
The Oncologist Outcomes Research Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis DIANNE PULTE, a,b HERMANN BRENNER a a Division of Clinical Epidemiology
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationORIGINAL ARTICLE. Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia
ORIGINAL ARTICLE Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia Incidence, Stage, and Outcome Nitin A. Pagedar, MD; Thorvardur R. Halfdanarson, MD; Lucy H. Karnell, PhD;
More informationORIGINAL ARTICLE. US Mortality Rates for Oral Cavity and Pharyngeal Cancer by Educational Attainment
ORIGINAL ARTICLE US Mortality Rates for Oral Cavity and Pharyngeal Cancer by Educational Attainment Amy Y. Chen, MD, MPH; Carol DeSantis, MPH; Ahmedin Jemal, PhD Objective: To describe trends in mortality
More informationThe Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER
The Effect of Changing Hysterectomy Prevalence on Trends in Endometrial Cancer, SEER 1992-2008 Annie Noone noonea@mail.nih.gov Missy Jamison, Lynn Ries, Brenda Edwards NAACCR 2012 Portland, OR Outline
More informationPatterns of adolescent smoking initiation rates by ethnicity and sex
ii Tobacco Control Policies Project, UCSD School of Medicine, San Diego, California, USA C Anderson D M Burns Correspondence to: Dr DM Burns, Tobacco Control Policies Project, UCSD School of Medicine,
More informationPAPILLARY THYROID CANCER IS A
ORIGINAL ARTICLE Thyroid Cancer Survival in the United States Observational Data From 1973 to 2005 Louise Davies, MD, MS; H. Gilbert Welch, MD, MPH Objective: To compare the survival rate of people with
More informationSTUDY. Analysis of the Melanoma Epidemic, Both Apparent and Real
Analysis of the Melanoma Epidemic, Both Apparent and Real Data From the 1973 Through 1994 Surveillance, Epidemiology, and End Results Program Registry Leslie K. Dennis, PhD STUDY Background: The incidence
More informationBLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER
BLACK-WHITE DIFFERENCES IN SURVIVAL FROM LATE-STAGE PROSTATE CANCER Objective: To examine differences between African Americans (Blacks) and non-hispanic Whites in risk of death after diagnosis of laterstage
More informationRare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers,
Rare Cancer Prevalence in the SEER Population: Hepatobiliary Cancers, 1975-2015 NAACCR 2018 Annual Conference Andrea Ayers, MPH Outline 1. Rare cancer classification 2. Hepatobiliary cancers 3. Key analytic
More informationTrends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
More informationCCSS Concept Proposal Working Group: Biostatistics and Epidemiology
Draft date: June 26, 2010 CCSS Concept Proposal Working Group: Biostatistics and Epidemiology Title: Conditional Survival in Pediatric Malignancies: A Comparison of CCSS and SEER Data Proposed Investigators:
More informationRESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry
DOI:http://dx.doi.org/.734/APJCP.22.3..568 RESEARCH ARTICLE Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry Mai Utada *, Yuko
More informationJ Clin Oncol 26: by American Society of Clinical Oncology INTRODUCTION
VOLUME 26 NUMBER 4 FEBRUARY 1 28 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Incidence Trends for Human Papillomavirus Related and Unrelated Oral Squamous Cell Carcinomas in the United States
More informationMortality from cancer of the lung in Serbia
JBUON 2013; 18(3): 723-727 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Mortality from cancer of the lung in Serbia M. Ilic 1, H. Vlajinac 2,
More informationHEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES. Daniel C.
HEALTH EFFECTS OF PRESERVED WOOD: RELATIONSHIP BETWEEN CCA- TREATED WOOD AND INCIDENCE OF CANCER IN THE UNITED STATES Daniel C. West, MD Associate Professor of Pediatrics University of California, Davis
More informationTHE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER
THE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER Casey A. Boyd, Jaime Benarroch, Kristin M. Sheffield, Yimei Han, Catherine D. Cooksley, Taylor S. Riall Department of Surgery The University of Texas Medical
More informationHysterectomy-Corrected Rates of Endometrial Cancer among Women of Reproductive Age
Hysterectomy-Corrected Rates of Endometrial Cancer among Women of Reproductive Age Annie Noone noonea@mail.nih.gov NAACCR 2017 Albuquerque, NM Motivation Cancer incidence rates are typically calculated
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationReport on Cancer Statistics in Alberta. Breast Cancer
Report on Cancer Statistics in Alberta Breast Cancer November 2009 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of the
More informationBiological Cure. Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D.
Using Cure Models to Estimate Biological Cure Margaret R. Stedman, Ph.D. MPH Angela B. Mariotto, Ph.D. Data Modeling Branch Surveillance Research Program Division of Cancer Control and Population Sciences
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationReport on Cancer Statistics in Alberta. Kidney Cancer
Report on Cancer Statistics in Alberta Kidney Cancer November 29 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of the Report
More informationDuring the past 2 decades, an increase in the ageadjusted
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:104 110 Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study JESSICA A. DAVILA* and HASHEM B. EL SERAG*,
More informationOverview of Hong Kong Cancer Statistics of 2015
Overview of Hong Kong Cancer Statistics of 2015 This report summarizes the key cancer statistics of Hong Kong for the year of 2015, which is now available on the website of Hong Kong Cancer Registry. Cancer
More informationSMOKING AND LUNG CANCER IN SOUTHERN NC: What the data tell us. Lynn Erdman, RN, MN, OCNS American Cancer Society
SMOKING AND LUNG CANCER IN SOUTHERN NC: What the data tell us Lynn Erdman, RN, MN, OCNS American Cancer Society Tobacco and Cancer Tobacco use remains the leading preventable cause of death and disease
More informationReport on Cancer Statistics in Alberta. Melanoma of the Skin
Report on Cancer Statistics in Alberta Melanoma of the Skin November 29 Surveillance - Cancer Bureau Health Promotion, Disease and Injury Prevention Report on Cancer Statistics in Alberta - 2 Purpose of
More informationSurvival in sinonasal and middle ear malignancies: a population-based study using the SEER database
Gore BMC Ear, Nose and Throat Disorders (2018) 18:13 https://doi.org/10.1186/s12901-018-0061-4 RESEARCH ARTICLE Open Access Survival in sinonasal and middle ear malignancies: a population-based study using
More informationAlthough African American women have a lower incidence of. Histologic Grade, Stage, and Survival in Breast Carcinoma
908 Histologic Grade, Stage, and Survival in Breast Carcinoma Comparison of African American and Caucasian Women Donald Earl Henson, M.D. 1 Kenneth C. Chu, Ph.D. 2 Paul H. Levine, M.D. 3 1 Department of
More informationChanges in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS
Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS David M. Burns, Jacqueline M. Major, Thomas G. Shanks INTRODUCTION Smoking norms and behaviors have
More informationKey Words. SEER Cancer Survival Incidence Mortality Prevalence
The Oncologist Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program LYNN A. GLOECKLER RIES, MARSHA E. REICHMAN, DENISE RIEDEL LEWIS, BENJAMIN F. HANKEY, BRENDA
More informationDescriptive Epidemiology: U.S. Patterns
Descriptive Epidemiology: U.S. Patterns Linda Morris Brown, Gloria Gridley, and Susan S. Devesa Abbreviations US HN SEER HPV ICD-O-3 API AI/AN United States head and neck Surveillance, Epidemiology, and
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationWojciech K. Mydlarz, M.D. Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue
Wojciech K. Mydlarz, M.D. Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue Disclosures No Relevant Financial Relationships or Commercial Interests Educational Objectives
More informationPopulation Based Survival of Female Breast Cancer Cases in Riyadh Region, Saudi Arabia
RESEARCH COMMUNICATION Population Based Survival of Female Breast Cancer Cases in Riyadh Region, Saudi Arabia K Ravichandran 1, Nasser Al Hamdan 2, Abdul Rahman Al Dyab 3 Abstract Breast cancer is the
More informationSTUDY. The Association of Medicare Health Care Delivery Systems With Stage at Diagnosis and Survival for Patients With Melanoma
STUDY The Association of Medicare Health Care Delivery Systems With Stage at Diagnosis and Survival for Patients With Melanoma Robert S. Kirsner, MD, PhD; James D. Wilkinson, MD, MPH; Fangchao Ma, MD,
More informationHealth Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, FOR
Health Consultation CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 2001-2005 FOR TOWNSHIP OF TOMS RIVER, OCEAN COUNTY, NEW JERSEY AUGUST 20, 2008 U.S. DEPARTMENT OF HEALTH
More informationLung cancer is the second most common type of. Lung Cancer in Women* Analysis of the National Surveillance, Epidemiology, and End Results Database
Lung Cancer in Women* Analysis of the National Surveillance, Epidemiology, and End Results Database Jennifer B. Fu, MD; T. Ying Kau, PhD; Richard K. Severson, PhD; and Gregory P. Kalemkerian, MD Objectives:
More informationIntroduction, Summary, and Conclusions
Chapter 1 Introduction, Summary, and Conclusions David M. Burns, Lawrence Garfinkel, and Jonathan M. Samet Cigarette smoking is the largest preventable cause of death and disability in developed countries
More informationA Methodological Issue in the Analysis of Second-Primary Cancer Incidence in Long-Term Survivors of Childhood Cancers
American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 11 Printed in U.S.A. DOI: 10.1093/aje/kwg278 PRACTICE OF EPIDEMIOLOGY
More informationImpact of PSA Screening on Prostate Cancer Incidence and Mortality in the US
Impact of PSA Screening on Prostate Cancer Incidence and Mortality in the US Deaths per 100,000 Ruth Etzioni Fred Hutchinson Cancer Research Center JASP Symposium, Montreal 2006 Prostate Cancer Incidence
More informationIn Canada, as in other parts of the
Trends in Histopathology of Lung Cancer in Alberta Juanita Hatcher, PhD Douglas C. Dover, MSc ABSTRACT Objective: To describe the trends over calendar period and birth cohort in lung cancer incidence by
More informationELIZABETH CEDARS DR. KOREY HOOD Available September 29
ELIZABETH CEDARS DR. KOREY HOOD Available September 29 Title and Investigators Optimizing Surgical Management of Thyroid Cancer: Using Surgeon-performed Ultrasound to Predict Extrathyroidal Extension of
More informationHealth Effects of Preserved Wood: Relationship Between CCA-Treated Wood and Incidence of Cancer in the United States
Health Effects of Preserved Wood: Relationship Between CCA-Treated Wood and Incidence of Cancer in the United States Daniel C. West, MD Associate Professor of Pediatrics University of California, Davis
More informationMalignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck
The Laryngoscope VC 2017 The American Laryngological, Rhinological and Otological Society, Inc. Malignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck Robert
More informationThe effect of multiple primary rules on cancer incidence rates and trends
The effect of multiple primary rules on cancer incidence rates and trends Hannah K. Weir, Centers for Disease Control and Prevention Christopher J. Johnson, Cancer Data Registry of Idaho Kevin C. Ward,
More informationLip. 1. Introduction. 1.1 General Information and Aetiology
Lip 1. Introduction 1.1 General Information and Aetiology Lips are the external part of the mouth. They are bounded externally by facial skin. On the oral cavity side, they are continuous with buccal mucosa
More informationGeographic Variations in Breast Cancer Survival Among Older Women: Implications for Quality of Breast Cancer Care
Journal of Gerontology: MEDICAL SCIENCES 2002, Vol. 57A, No. 6, M401 M406 Copyright 2002 by The Gerontological Society of America Geographic Variations in Breast Cancer Survival Among Older Women: Implications
More informationLARYNGEAL CANCER AT THE KORLE BU TEACHING HOSPITAL ACCRA GHANA
LARYNGEAL CANCER AT THE KORLE BU TEACHING HOSPITAL ACCRA GHANA * E.D. KITCHER, J. YARNEY 1, R.K. GYASI 2 AND C. CHEYUO Departments of Surgery and 2 Pathology, University of Ghana Medical School, P O Box
More informationTrends in the incidence of thyroid cancer, Israel,
Trends in the incidence of thyroid cancer, Israel, 1980-2012 Lital Keinan-Boker, MD, MPH, PhD, Barbara G. Silverman, MD, MPH Israel National Cancer Registry Israel Center for Disease Control Israel Ministry
More informationOral Cavity and Oropharynx Cancer Trends
Oral Cavity and Oropharynx Cancer Trends Darien Weatherspoon, DDS, MPH Diplomate, American Board of Dental Public Health Program Officer, National Institute of Dental and Craniofacial Research National
More informationUse of Joinpoint Regression to Define Phases of Care From Diagnosis of Metastases Until Death in Patients With Advanced Melanoma
Use of Joinpoint Regression to Define Phases of Care From Diagnosis of Metastases Until Death in Patients With Advanced Melanoma Sasikiran Nunna, MS 1 Anna D. Coutinho, B.Pharm, PhD 2 Michael Eaddy, PharmD,
More informationEthnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,
Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD, MD, Paul Hebert, PhD, Michael C. Iannuzzi, MD, and
More informationQuantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme
British Journal of Cancer (2002) 87, 65 69 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme
More informationORIGINAL ARTICLE. Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma
ORIGINAL ARTICLE Incidence and Survival Rates for Young Blacks With Nasopharyngeal Carcinoma in the United States Luke M. Richey, BA; Andrew F. Olshan, PhD; Jonathan George, BA; Carol G. Shores, MD, PhD;
More informationThe Relationship between and Geographic Distribution of Breast Cancer Statistics:
The Relationship between and Geographic Distribution of Breast Cancer Statistics: Diagnosis, Survival, and Mortality in Selected Areas in the United States, 1973-2004 1 Timothy Rooney Dr. Charles Becker,
More informationKey Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER
The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW
More informationDiagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017
Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations
More informationAnnual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Public Health Resources Public Health Resources 7-1-2004 Annual Report to the Nation on the Status of Cancer, 1975 2001,
More informationAssociation between Age, Tumour Location and Survival of Patients in Morocco
Journal of Cancer and Tumor International 1(1):.., 2014 SCIENCEDOMAIN international www.sciencedomain.org Association between Age, Tumour Location and Survival of Patients in Morocco A. Sbayi 1, A. Arfaoui
More informationCANCER INCIDENCE NEAR THE BROOKHAVEN LANDFILL
CANCER INCIDENCE NEAR THE BROOKHAVEN LANDFILL CENSUS TRACTS 1591.03, 1591.06, 1592.03, 1592.04 AND 1593.00 TOWN OF BROOKHAVEN, SUFFOLK COUNTY, NEW YORK, 1983-1992 WITH UPDATED INFORMATION ON CANCER INCIDENCE
More informationSmoking-attributable cancer mortality in California, 1979e2005
1 California Department of Public Health, CDIC/California Tobacco Control Program, Sacramento, California, USA 2 Sequoia Foundation, Richmond, California, USA Correspondence to David Cowling, California
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More informationCANCER SURVEILLANCE SERIES
CANCER SURVEILLANCE SERIES Recent Trends in Lung Cancer Mortality in the United States Ahmedin Jemal, Kenneth C. Chu, Robert E. Tarone Background: Previous age period cohort analyses of lung cancer incidence
More informationNational Cervical Screening Programme. Annual Report 2014
National Cervical Screening Programme Annual Report 2014 Report prepared February 2017 Revised May 2017 Finalised June 2017 Report prepared by Megan Smith, Leanne Rumlee and Karen Canfell. Cancer Research
More informationInternational Analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, 10th Revision
original report International Analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, th Revision Paolo Boffetta Matteo Malvezzi Enrico
More informationUpdates on the Conflict of Postoperative Radiotherapy Impact on Survival of Young Women with Cancer Breast: A Retrospective Cohort Study
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(7): 14-18 I J M R
More informationDo morphology and stage explain the inferior lung cancer survival in Denmark?
Eur Respir J 1999; 13: 430±435 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Do morphology and stage explain the inferior lung cancer
More informationIncidence of Surgically Treated Benign Prostatic Hypertrophy and of Prostate Cancer among Blacks and Whites in a Prepaid Health Care Plan
American Journal of EpKtermotogy Vo! 134, No 8 Copyright C 1991 by The Johns Hopkrts Uruversfty School of Hygiene and Put*: Health Printed in US A AS rights reserved A BRIEF ORIGINAL CONTRIBUTION Incidence
More informationHypopharynx. 1. Introduction. 1.1 General Information and Aetiology
Hypopharynx 1. Introduction 1.1 General Information and Aetiology The human pharynx is the part of the throat situated between the nasal cavity and the esophagus and can be divided into three parts: the
More informationClinico-etiopathological and management profile of laryngeal tumours in a tertiary care centre
International Journal of Otorhinolaryngology and Head and Neck Surgery Pal P et al. Int J Otorhinolaryngol Head Neck Surg. 2017 Oct;3(4):913-917 http://www.ijorl.com pissn 2454-5929 eissn 2454-5937 Original
More informationLife expectancy in the United States continues to lengthen.
Reduced Mammographic Screening May Explain Declines in Breast Carcinoma in Older Women Robert M. Kaplan, PhD and Sidney L. Saltzstein, MD, MPH wz OBJECTIVES: To examine whether declines in breast cancer
More informationORIGINAL ARTICLE. Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx
ORIGINAL ARTICLE Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx Sandro J. Stoeckli, MD; Andreas B. Pawlik, MD; Margareta Lipp, MD; Alexander Huber, MD;
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 2, March 2014
INCIDENCE OF PRIMARY HEAD AND NECK CANCERS AT B K L W HOSPITAL & RURAL MEDICAL COLLEGE, A TERTIARY CARE CENTRE IN KONKAN, MAHARASHTRA RAJASHREE A KULKARNI* MAHESH S PATIL** *Assistant Professor, Dept.
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationLUNG CANCER Includes Invasive and Primary Cancers Only; Does Not Include Carcinoma In Situ or Metastatic Cancer
1 ONC 14 LUNG CANCER Includes Invasive and Primary Cancers Only; Does Not Include Carcinoma In Situ or Metastatic Cancer Background This case definition was developed in 2010 by the Armed Forces Health
More informationRacial and Social Economic Factors Impact on the Cause Specific Survival of Pancreatic Cancer: A SEER Survey
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.1.159 RESEARCH ARTICLE Racial and Social Economic Factors Impact on the Cause Specific Survival of Pancreatic Cancer: A SEER Survey Rex Cheung Abstract Background:
More informationTrends in Leukemia Incidence and Survival in the United States ( )
2229 Trends in Leukemia Incidence and Survival in the United States (1973 1998) Yang Xie, M.D., M.P.H. 1,2 Stella M. Davies, M.D., Ph.D. 1,2 Ying Xiang, M.D. 1,2 Leslie L. Robison, Ph.D. 1,2 Julie A. Ross,
More informationBreast Cancer After Treatment of Hodgkin's Disease.
Breast Cancer After Treatment of Hodgkin's Disease. Hancock SL, Tucker MA, Hoppe R Journal of the National Cancer Institute 85(1):25-31, 1993 Introduction The risks of second malignancy are increased in
More informationCarcinoma of the breast in East Anglia : a changing pattern of presentation?
Journal oj'epidemiology and Community Health, 1978, 32, 178-182 Carcinoma of the breast in East Anglia 196-1975: a changing pattern of presentation? ANNE M. DE BONO AND E. M. KINGSLEY PILLERS From the
More informationComparison of Survival Rates between Chinese and Thai Patients with Breast Cancer
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6029 RESEARCH ARTICLE Comparison of Survival Rates between Chinese and Thai Patients with Breast Cancer Yanhua Che 1,4, Jing You 2, Shaojiang Zhou 3, Li Li
More informationSurvival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer
Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer Jayashree Kalpathy-Cramer PhD 1, William Hersh, MD 1, Jong Song Kim, PhD
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1-: Annual Report of the National Cancer Registry ABBREVIATIONS % CI % confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) CNS Central
More informationclinical investigations The Experience of an Academic Multidisciplinary Program
clinical investigations Lung Cancer in Patients < 50 Years of Age* The Experience of an Academic Multidisciplinary Program Shirish M. Gadgeel, MD; Sakkaraiappan Ramalingam, MD; Glenn Cummings, PhD; Michael
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More information2018 Texas Cancer Registry Annual Report
2018 Texas Cancer Registry Annual Report As Required by Texas Health and Safety Code Section 82.007 November 2018 Table of Contents Executive Summary... 1 1. Introduction... 2 2. Background... 3 Cancer
More informationThe incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature
ORIGINAL ARTICLE The incidence of salivary carcinoma ex pleomorphic adenoma: A SEER database review and review of the literature Carl Rebhun, Richard O. Wein 1. School of Medicine, Tufts University, United
More informationTHE IMPORTANCE OF COMORBIDITY TO CANCER CARE AND STATISTICS AMERICAN CANCER SOCIETY PRESENTATION COPYRIGHT NOTICE
THE IMPORTANCE OF COMORBIDITY TO CANCER CARE AND STATISTICS AMERICAN CANCER SOCIETY PRESENTATION COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity
More informationThe American Cancer Society estimates that there will be
ORIGINAL ARTICLE Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,* David M. Kent, MD, MS, and Gary M.
More informationThe role of primary surgical treatment in young patients with squamous cell carcinoma of the larynx: a 20-year review of 34 cases
Wang et al. World Journal of Surgical Oncology (2015) 13:283 DOI 10.1186/s12957-015-0699-y WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access The role of primary surgical treatment in young patients
More informationChibueze Onyemkpa 1, Alan Davis 1, Michael McLeod 1, Tolutope Oyasiji 1,2. Original Article
Original Article Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile
More informationOVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER
OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER Author Chayawut Punsriwong Chayakamon Niyasom Pariphat Chompoonutprapa Sarut Pravitkulawath 5 th year medical student Naresuan University
More informationSurvival impact of cervical metastasis in squamous cell carcinoma of hard palate
Vol. 116 No. 1 July 2013 Survival impact of cervical metastasis in squamous cell carcinoma of hard palate Quan Li, MD, a Di Wu, MD, b,c Wei-Wei Liu, MD, PhD, b,c Hao Li, MD, PhD, b,c Wei-Guo Liao, MD,
More informationDownloaded from:
Coleman, MP; Quaresma, M; Butler, J; Rachet, B (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK Reply. Lancet, 377 (9772). pp. 1149-1150. ISSN 0140-6736 Downloaded from:
More informationGastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors
Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)
More information